Raised $162M across disclosed rounds.[3][4]

Series C closed June 2025, led by IVP.[1][2][3][12]

post-money valuation is not publicly disclosed.

Named investors include IVP, Andreessen Horowitz, Lightspeed Venture Partners, GV (Google Ventures), ICONIQ, Foundation Capital, Y Combinator, Frank Slootman.[2][3][4][5][12]

Trey Holterman, Co-Founder & CEO[1][3][5][7]

Tyler Johnson, Co-Founder & CTO[1][3][5][7]

Diego Baugh, Co-Founder & Chief Product Officer[1][3][5][7]

Rob Bressler, SVP & GM, Growth[8][9][10][11]

Kenny Herman, Chief Business Development Officer[8][9][10][11]

Ashley F., Vice President of Legal and Compliance[8][9][10][11]

William H. Morris, Chief Medical Officer[8][9][10][11]

David Farber, Chief Financial Officer[8][9][10][11]

Filled in the side panel for invited readers. This card carries sourced facts only.